A presentation:
Partly because we under-invested in the technology.
Remember, even if off-the-shelf stuff like HCQ and Remdesivir fail, we have LOTS of candidate treatments in the pipeline!!
With funding for tons of tests and contact tracing employees, of course.
There's really no substitute, folks. We need it.
A thread:
twitter.com/Noahpinion/lis…
(end)